Radiation therapy for breast cancer causes side effects in nearly every patient, though the severity varies widely. More than 90% of people receiving radiation develop some degree of skin irritation, and about a third experience persistent fatigue that can linger well beyond treatment. Most side effects are temporary and manageable, but some, like tissue firmness and sensitivity changes, can develop months or years later.
Skin Reactions During and After Treatment
Skin irritation is the most common side effect of breast radiation. The treated area typically becomes itchy and dry within the first few weeks, then may progress to look and feel like a sunburn. In some cases, the skin develops moist or weeping patches, similar to a blister that has opened. About 20% of patients develop reactions severe enough to interfere with daily life or make them consider pausing treatment.
The timing can be unpredictable. Some people notice dryness during their very first week, while others don’t develop noticeable irritation until they’re a quarter of the way through their treatment schedule. A smaller number don’t experience skin changes until after their final session, because radiation continues to affect cells for weeks after treatment ends. The good news is that most skin symptoms clear up within a few weeks of finishing radiation, though the area can remain sensitive for about a month afterward.
During treatment, the skin on the treated breast may darken or take on a tanned appearance. This discoloration usually fades gradually but can persist for several months in some people, particularly those with lighter skin tones.
Fatigue That Can Persist for Months
Fatigue is the second most common complaint, and it’s often more disruptive than people expect. Unlike ordinary tiredness, radiation-related fatigue doesn’t necessarily improve with rest. It tends to build gradually over the course of treatment and can peak in the weeks after your last session.
For most people, energy levels return to normal within a few months. But roughly a third of breast cancer survivors still report significant fatigue a full year after treatment. Data on long-term survivors suggest fatigue can persist for up to five years, and in some cases even longer. Younger patients and those receiving chemotherapy alongside radiation tend to be hit harder.
Long-Term Breast Changes
In the months and years following radiation, the treated breast can develop lasting physical changes. Between 30% and 70% of patients develop some degree of fibrosis, a process where normal soft tissue is gradually replaced by firmer, less elastic tissue. The breast may feel thicker or denser than before, and it can shrink slightly over time. Up to 30% of patients receiving radiation to the breast or chest wall develop severe fibrosis that noticeably affects how the breast looks and feels.
These changes happen because radiation damages the connective tissue’s ability to repair itself normally. Instead of regenerating, the tissue scars internally. The result can include skin tightening, reduced flexibility in the chest wall, and slower wound healing in the treated area. These effects are permanent in most cases, though they tend to stabilize rather than continue worsening indefinitely.
Chronic Pain and Sensitivity
Ongoing breast pain after radiation is more common than many patients realize. Across large studies, roughly 27% of women who received radiation therapy reported lasting breast pain afterward. Age plays a significant role: among women treated before age 40, about 23% reported persistent pain, compared to roughly 9% of women older than 60. Studies tracking patients anywhere from 3 to 17 years after treatment have confirmed that this pain can be genuinely long-lasting, not just a slow recovery.
The pain is typically described as aching, tenderness, or shooting sensations in the treated breast and surrounding chest wall. It can be triggered by touch, physical activity, or changes in weather. For most women who experience it, the pain is mild to moderate and manageable, but it can affect clothing choices, sleep comfort, and physical intimacy.
Lung Irritation
Because the breast sits directly over the lung, some radiation inevitably reaches lung tissue. A small percentage of patients, roughly 2%, develop radiation pneumonitis, an inflammation of the lung that typically appears one to six months after treatment ends. Symptoms include a progressive cough, shortness of breath, and occasionally fever.
Modern radiation techniques have made this complication uncommon. Treatment planning uses imaging to minimize the volume of lung tissue exposed, and techniques like deep inspiration breath hold (where you take a deep breath during treatment to move the lung away from the radiation beam) have further reduced the risk. When pneumonitis does occur, it usually resolves with a course of anti-inflammatory medication.
Arm Swelling
Lymphedema, a chronic swelling of the arm on the treated side, is a well-known concern after breast cancer treatment. However, the risk from radiation alone (to the breast or chest wall only) is quite low. Research shows that radiation to the breast without extensive lymph node treatment does not significantly increase lymphedema risk beyond what surgery alone causes. The primary driver of lymphedema is the removal of axillary lymph nodes during surgery, not the radiation itself. If your treatment plan includes radiation to the lymph node regions as well as the breast, your care team will discuss this risk with you specifically.
Nerve Damage
Radiation-induced brachial plexopathy, damage to the network of nerves running from the neck through the shoulder and into the arm, is rare but serious. It occurs in about 1.2% of women irradiated for breast cancer, primarily those who receive radiation to the lymph node areas above the collarbone. Symptoms usually develop gradually: tingling or numbness in the hand or arm appears first, followed by pain, and in some cases, progressive weakness. Because the onset is slow (often months to years after treatment), it can be difficult to connect to radiation initially.
Secondary Cancer Risk
Radiation therapy slightly increases the long-term risk of developing a new, unrelated cancer in the treated area. At 10 years, the cumulative incidence of a secondary cancer (excluding the opposite breast) is about 11.9% for women who received radiation, compared to 11.4% for those who did not. At 20 years, the gap widens slightly: 26.4% versus 23.1%. These numbers include all types of secondary cancers, and the absolute difference, roughly 3 percentage points at 20 years, is relatively small when weighed against the survival benefit radiation provides for the original breast cancer.
The cancers most associated with prior chest radiation include lung cancer and cancers of the esophagus and soft tissues. The risk is higher for women treated at younger ages, because they have more remaining years in which a radiation-related cancer could develop. This is one reason oncologists carefully weigh the benefits and risks of radiation, particularly for younger patients with lower-risk breast cancers.